purchase customization

1 Study Coverage
1.1 Chronic Urticaria Or Hives Drug Product Introduction
1.2 Market by Type
1.2.1 Global Chronic Urticaria Or Hives Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 GDC-0853
1.2.3 GSK-2646264
1.2.4 BF-Derm-1
1.2.5 Bilastine
1.2.6 Others
1.3 Market by Application
1.3.1 Global Chronic Urticaria Or Hives Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Chronic Urticaria Or Hives Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Chronic Urticaria Or Hives Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Chronic Urticaria Or Hives Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Chronic Urticaria Or Hives Drug Sales by Region
2.4.1 Global Chronic Urticaria Or Hives Drug Sales by Region (2017-2022)
2.4.2 Global Sales Chronic Urticaria Or Hives Drug by Region (2023-2028)
2.5 Global Chronic Urticaria Or Hives Drug Revenue by Region
2.5.1 Global Chronic Urticaria Or Hives Drug Revenue by Region (2017-2022)
2.5.2 Global Chronic Urticaria Or Hives Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Chronic Urticaria Or Hives Drug Sales by Manufacturers
3.1.1 Global Top Chronic Urticaria Or Hives Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Chronic Urticaria Or Hives Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Chronic Urticaria Or Hives Drug in 2021
3.2 Global Chronic Urticaria Or Hives Drug Revenue by Manufacturers
3.2.1 Global Chronic Urticaria Or Hives Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Chronic Urticaria Or Hives Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Chronic Urticaria Or Hives Drug Revenue in 2021
3.3 Global Chronic Urticaria Or Hives Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Chronic Urticaria Or Hives Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Chronic Urticaria Or Hives Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Chronic Urticaria Or Hives Drug Sales by Type
4.1.1 Global Chronic Urticaria Or Hives Drug Historical Sales by Type (2017-2022)
4.1.2 Global Chronic Urticaria Or Hives Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Chronic Urticaria Or Hives Drug Sales Market Share by Type (2017-2028)
4.2 Global Chronic Urticaria Or Hives Drug Revenue by Type
4.2.1 Global Chronic Urticaria Or Hives Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Chronic Urticaria Or Hives Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Chronic Urticaria Or Hives Drug Revenue Market Share by Type (2017-2028)
4.3 Global Chronic Urticaria Or Hives Drug Price by Type
4.3.1 Global Chronic Urticaria Or Hives Drug Price by Type (2017-2022)
4.3.2 Global Chronic Urticaria Or Hives Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Chronic Urticaria Or Hives Drug Sales by Application
5.1.1 Global Chronic Urticaria Or Hives Drug Historical Sales by Application (2017-2022)
5.1.2 Global Chronic Urticaria Or Hives Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Chronic Urticaria Or Hives Drug Sales Market Share by Application (2017-2028)
5.2 Global Chronic Urticaria Or Hives Drug Revenue by Application
5.2.1 Global Chronic Urticaria Or Hives Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Chronic Urticaria Or Hives Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Chronic Urticaria Or Hives Drug Revenue Market Share by Application (2017-2028)
5.3 Global Chronic Urticaria Or Hives Drug Price by Application
5.3.1 Global Chronic Urticaria Or Hives Drug Price by Application (2017-2022)
5.3.2 Global Chronic Urticaria Or Hives Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Chronic Urticaria Or Hives Drug Market Size by Type
6.1.1 North America Chronic Urticaria Or Hives Drug Sales by Type (2017-2028)
6.1.2 North America Chronic Urticaria Or Hives Drug Revenue by Type (2017-2028)
6.2 North America Chronic Urticaria Or Hives Drug Market Size by Application
6.2.1 North America Chronic Urticaria Or Hives Drug Sales by Application (2017-2028)
6.2.2 North America Chronic Urticaria Or Hives Drug Revenue by Application (2017-2028)
6.3 North America Chronic Urticaria Or Hives Drug Market Size by Country
6.3.1 North America Chronic Urticaria Or Hives Drug Sales by Country (2017-2028)
6.3.2 North America Chronic Urticaria Or Hives Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Chronic Urticaria Or Hives Drug Market Size by Type
7.1.1 Europe Chronic Urticaria Or Hives Drug Sales by Type (2017-2028)
7.1.2 Europe Chronic Urticaria Or Hives Drug Revenue by Type (2017-2028)
7.2 Europe Chronic Urticaria Or Hives Drug Market Size by Application
7.2.1 Europe Chronic Urticaria Or Hives Drug Sales by Application (2017-2028)
7.2.2 Europe Chronic Urticaria Or Hives Drug Revenue by Application (2017-2028)
7.3 Europe Chronic Urticaria Or Hives Drug Market Size by Country
7.3.1 Europe Chronic Urticaria Or Hives Drug Sales by Country (2017-2028)
7.3.2 Europe Chronic Urticaria Or Hives Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Chronic Urticaria Or Hives Drug Market Size by Type
8.1.1 Asia Pacific Chronic Urticaria Or Hives Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Chronic Urticaria Or Hives Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Chronic Urticaria Or Hives Drug Market Size by Application
8.2.1 Asia Pacific Chronic Urticaria Or Hives Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Chronic Urticaria Or Hives Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Chronic Urticaria Or Hives Drug Market Size by Region
8.3.1 Asia Pacific Chronic Urticaria Or Hives Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Chronic Urticaria Or Hives Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Chronic Urticaria Or Hives Drug Market Size by Type
9.1.1 Latin America Chronic Urticaria Or Hives Drug Sales by Type (2017-2028)
9.1.2 Latin America Chronic Urticaria Or Hives Drug Revenue by Type (2017-2028)
9.2 Latin America Chronic Urticaria Or Hives Drug Market Size by Application
9.2.1 Latin America Chronic Urticaria Or Hives Drug Sales by Application (2017-2028)
9.2.2 Latin America Chronic Urticaria Or Hives Drug Revenue by Application (2017-2028)
9.3 Latin America Chronic Urticaria Or Hives Drug Market Size by Country
9.3.1 Latin America Chronic Urticaria Or Hives Drug Sales by Country (2017-2028)
9.3.2 Latin America Chronic Urticaria Or Hives Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Chronic Urticaria Or Hives Drug Market Size by Type
10.1.1 Middle East and Africa Chronic Urticaria Or Hives Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Chronic Urticaria Or Hives Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Chronic Urticaria Or Hives Drug Market Size by Application
10.2.1 Middle East and Africa Chronic Urticaria Or Hives Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Chronic Urticaria Or Hives Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Chronic Urticaria Or Hives Drug Market Size by Country
10.3.1 Middle East and Africa Chronic Urticaria Or Hives Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Chronic Urticaria Or Hives Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 AstraZeneca Plc
11.1.1 AstraZeneca Plc Corporation Information
11.1.2 AstraZeneca Plc Overview
11.1.3 AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 AstraZeneca Plc Chronic Urticaria Or Hives Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AstraZeneca Plc Recent Developments
11.2 Biofrontera AG
11.2.1 Biofrontera AG Corporation Information
11.2.2 Biofrontera AG Overview
11.2.3 Biofrontera AG Chronic Urticaria Or Hives Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Biofrontera AG Chronic Urticaria Or Hives Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Biofrontera AG Recent Developments
11.3 ELORAC, Inc.
11.3.1 ELORAC, Inc. Corporation Information
11.3.2 ELORAC, Inc. Overview
11.3.3 ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 ELORAC, Inc. Chronic Urticaria Or Hives Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 ELORAC, Inc. Recent Developments
11.4 Faes Farma, SA
11.4.1 Faes Farma, SA Corporation Information
11.4.2 Faes Farma, SA Overview
11.4.3 Faes Farma, SA Chronic Urticaria Or Hives Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Faes Farma, SA Chronic Urticaria Or Hives Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Faes Farma, SA Recent Developments
11.5 Genentech, Inc.
11.5.1 Genentech, Inc. Corporation Information
11.5.2 Genentech, Inc. Overview
11.5.3 Genentech, Inc. Chronic Urticaria Or Hives Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Genentech, Inc. Chronic Urticaria Or Hives Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Genentech, Inc. Recent Developments
11.6 GlaxoSmithKline Plc
11.6.1 GlaxoSmithKline Plc Corporation Information
11.6.2 GlaxoSmithKline Plc Overview
11.6.3 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 GlaxoSmithKline Plc Recent Developments
11.7 J Uriach Y Compania, S.A.
11.7.1 J Uriach Y Compania, S.A. Corporation Information
11.7.2 J Uriach Y Compania, S.A. Overview
11.7.3 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 J Uriach Y Compania, S.A. Recent Developments
11.8 Mabtech Limited
11.8.1 Mabtech Limited Corporation Information
11.8.2 Mabtech Limited Overview
11.8.3 Mabtech Limited Chronic Urticaria Or Hives Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Mabtech Limited Chronic Urticaria Or Hives Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Mabtech Limited Recent Developments
11.9 Merck & Co., Inc.
11.9.1 Merck & Co., Inc. Corporation Information
11.9.2 Merck & Co., Inc. Overview
11.9.3 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Merck & Co., Inc. Recent Developments
11.10 Mycenax Biotech Inc.
11.10.1 Mycenax Biotech Inc. Corporation Information
11.10.2 Mycenax Biotech Inc. Overview
11.10.3 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Mycenax Biotech Inc. Recent Developments
11.11 Novartis AG
11.11.1 Novartis AG Corporation Information
11.11.2 Novartis AG Overview
11.11.3 Novartis AG Chronic Urticaria Or Hives Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Novartis AG Chronic Urticaria Or Hives Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Novartis AG Recent Developments
11.12 Panacea Biotec Limited
11.12.1 Panacea Biotec Limited Corporation Information
11.12.2 Panacea Biotec Limited Overview
11.12.3 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Panacea Biotec Limited Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Chronic Urticaria Or Hives Drug Industry Chain Analysis
12.2 Chronic Urticaria Or Hives Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Chronic Urticaria Or Hives Drug Production Mode & Process
12.4 Chronic Urticaria Or Hives Drug Sales and Marketing
12.4.1 Chronic Urticaria Or Hives Drug Sales Channels
12.4.2 Chronic Urticaria Or Hives Drug Distributors
12.5 Chronic Urticaria Or Hives Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Chronic Urticaria Or Hives Drug Industry Trends
13.2 Chronic Urticaria Or Hives Drug Market Drivers
13.3 Chronic Urticaria Or Hives Drug Market Challenges
13.4 Chronic Urticaria Or Hives Drug Market Restraints
14 Key Findings in The Global Chronic Urticaria Or Hives Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer